Placebo-controlled study on the efficacy of the pyrimido-pyrimidine derivative RA 233 in ovarian cancer

This publication has 13 references indexed in Scilit:

• Effect of Mopidamol on Survival in Carcinoma of the Lung and Colon: Final Report of Veterans Administration Cooperative Study No. 188
  JNCI Journal of the National Cancer Institute, 1988
• Mopidamol in Non-Small Cell Lung Cancer: Anti-Oncogene or Accident?
  JNCI Journal of the National Cancer Institute, 1988
• Common Epithelial Cancer of the Ovary
  New England Journal of Medicine, 1985
• Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary
  American Journal of Obstetrics and Gynecology, 1984
• A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1984
• Effect of RA233 alone and combined with radiation on experimental tumour metastasis. Part 1
  Clinical & Experimental Metastasis, 1983
• The effect of 2,6-bis(diethanolamino)-4-piperidinopyrimido [5,4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanoma
  Cancer Letters, 1982
• Reporting results of cancer treatment
  Cancer, 1981
• The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL)
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1976
• THE INHIBITION OF THE CANCER CELL STICKINESS BY PYRIMIDO‐PYRIMIDINE DERIVATES INDUCED BY INHIBITION OF PLATELET AGGREGATION
  Acta Medica Scandinavica, 1972